Infections After Lung Transplant

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

CSL Behring
CSL BehringIL - Bradley
1 program
SQ IVIGN/A1 trial
Active Trials
NCT01361178Completed133Est. Jan 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CSL BehringSQ IVIG

Clinical Trials (1)

Total enrollment: 133 patients across 1 trials

Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement

Start: Jan 2011Est. completion: Jan 2016133 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space